Abstract
Introduction: Trichohepatoenteric syndrome (THES) is caused by pathogenic mutations in TTC37 and SKIV2L genes and characterized by intractable diarrhea, facial dysmorphism, hair abnormality, immunodeficiency, and skin abnormalities. Lipoid proteinosis is caused by pathogenic mutations in ECM1 gene and characterized by deposition of hyaline-like material in various tissues resulting in heterogenous clinical findings. Case Presentation: Four years after the diagnosis and management of THES, due to new clinical findings, another reason for underlying features of the patient was considered. WES was performed and a homozygous c.507delT (p.Arg171GlyfsTer7) mutation in the ECM1 gene was detected. Conclusion: This case provides an example of co-existence of multiple genetic defects in a single patient born to consanguineous parents.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Agredano
PM
, Del Barrio
CM
, Martinez
MC
, Cabrera
CA
. Intracranial calcifications associated with epilepsy: a case report of lipoid proteinosis
. Seizure
. 2020
;83
:172
–4
.2.
Belliveau
MJ
, Alkhotani
A
, Ali
A
. Moniliform blepharosis of lipoid proteinosis
. JAMA Ophthalmol
. 2015
;133
(7
):e150688
.3.
Bourgeois
P
, Esteve
C
, Chaix
C
, Beroud
C
, Levy
N
THES clinical consortium
et al. Tricho-Hepato-Enteric Syndrome mutation update: mutations spectrum of TTC37 and SKIV2L, clinical analysis and future prospects
. Hum Mutat
. 2018
;39
(6
):774
–89
.4.
Chan
I
, Liu
L
, Hamada
T
, Sethuraman
G
, McGrath
JA
. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1
. Exp Dermatol
. 2007
;16
(11
):881
–90
.5.
Gonçalves
FG
, de Melo
MB
, de L Matos
V
, Barra
FR
, Figueroa
RE
. Amygdalae and striatum calcification in lipoid proteinosis
. AJNR Am J Neuroradiol
. 2010
;31
(1
):88
–90
.6.
Hamada
T
. Lipoid proteinosis
. Clin Exp Dermatol
. 2002
;27
(8
):624
–9
.7.
Hiejima
E
, Yasumi
T
, Nakase
H
, Matssura
M
, Honzawa
Y
, Higuchi
H
et al. Tricho-hepato-enteric syndrome with novel SKIVL2 gene mutations
. Medicine
. 2017
;96
:46
.8.
Karaca Edeer
N
, Aykut
A
, Parıltay
E
, Aksu
G
, Cogulu
O
, Kutukculer
N
. A novel TTC37 mutation causing clinical symptoms of trichohepatoenteric syndrome such as pyoderma gangrenosum and immunodeficiency without severe diarrhea
. J Investig Allergol Clin Immunol
. 2019
;29
(5
):396
–8
.9.
Lee
WS
, Teo
KM
, Ng
RT
, Chong
SY
, Kee
BP
, Chua
KH
. Novel mutations in SKIV2L and TTC37 genes in Malaysian children with trichohepatoenteric syndrome
. Gene
. 2016
;586
:1
–6
.10.
Ravi Prakash
SM
, Verma
S
, Sumalatha
MN
, Chattopadhyay
S
. Oral manifestations of lipoid proteinosis: a case report and literature review
. Saudi Dent J
. 2013
;25
(2
):91
–4
.11.
Savage
MM
, Crockett
DM
, McCabe
BF
. Lipoid proteinosis of the larynx: a cause of voice change in the infant and young child
. Int J Pediatr Otorhinolaryngol
. 1988
;15
(1
):33
–8
.12.
Siebert
M
, Markowitsch
HJ
, Bartel
P
. Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease
. Brain
. 2003
126
Pt 12
2627
37
.13.
Thornton
HB
, Nel
D
, Thornton
D
, van Honk
J
, Baker
GA
, Stein
DJ
. The neuropsychiatry and neuropsychology of lipoid proteinosis
. J Neuropsychiatry Clin Neurosci
. 2008
;20
(1
):86
–92
.14.
Vahidnezhad
H
, Youssefian
L
, Uitto
J
. Lipoid proteinosis
. In: Adam
MP
, Ardinger
HH
, Pagon
RA
et al, editors. GeneReviews®
Seattle (WA)
University of Washington, Seattle
. 2016 Jan 21
.15.
Vardi
I
, Barel
O
, Sperber
M
, Schvimer
M
, Nunberg
M
, Field
M
et al. Genetic and structural analysis of a SKIV2L mutation causing tricho-hepato-enteric syndrome
. Dig Dis Sci
. 2018
;63
(5
):1192
–9
.16.
Zheng
B
, Pan
J
, Jin
Y
, Wang
C
, Liu
Z
. Targeted next-generation sequencing identification of a novel missense mutation of the SKIV2L gene in a patient with trichohepatoenteric syndrome
. Mol Med Rep
. 2016
;14
(3
):2107
–10
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
